Deoxythymidine/Deoxycytidine

N/A

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameDeoxythymidine/Deoxycytidine
Drug Alias NameThymidine/DeoxycytidineDoxecitine/DoxribtimineDeoxycytidine/deoxythymidinedoxTMdC/dT +[7] 
ClassificationSmall molecules
Mechanisms of ActionDeoxyribonucleoside replacements
TargetsUpdating
Therapy Area/IndicationsThymidine kinase 2 deficiencyMitochondrial DiseasesMitochondrial Encephalomyopathies
Global Approved IndicationsThymidine kinase 2 deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/11/03
Country/TerritoryCanadaUnited StatesIsrael +[5] 
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesColumbia University Medical CenterHospital Vall D'Hebron Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesUcb IncUcb Pharma IncResearch Institute Of The Mcgill University Health Centre +[5] 
Inactive CompaniesZogenix MDS Inc
Active IndicationsThymidine kinase 2 deficiencyMitochondrial DiseasesMitochondrial Encephalomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A